Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.

Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Moeding A, Stessman M, Anderson JK, Monga M.

J Endourol. 2011 Mar;25(3):535-40. doi: 10.1089/end.2010.0241. Epub 2011 Mar 1.

PMID:
21361824
2.

Can obese stone formers follow dietary recommendations?

Torricelli FC, De S, Li I, Sarkissian C, Monga M.

J Endourol. 2014 Feb;28(2):248-51. doi: 10.1089/end.2013.0536. Epub 2013 Nov 4.

PMID:
24032438
3.

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.

Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Leavitt DA, Moeding A, Stessman M, Monga M.

Urology. 2012 Feb;79(2):282-6. doi: 10.1016/j.urology.2011.08.022. Epub 2011 Oct 13.

PMID:
22000931
4.

Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.

Trinchieri A, Lizzano R, Marchesotti F, Zanetti G.

Urol Res. 2006 Feb;34(1):1-7. Epub 2006 Jan 20.

PMID:
16425021
5.

The most important metabolic risk factors in recurrent urinary stone formers.

Parvin M, Shakhssalim N, Basiri A, Miladipour AH, Golestan B, Mohammadi Torbati P, Azadvari M, Eftekhari S.

Urol J. 2011 Spring;8(2):99-106.

6.

Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.

Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.

J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.

PMID:
19152919
7.

Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?

Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M.

Urol Int. 2003;70(4):273-7.

PMID:
12740490
8.

Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.

Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I.

Urol Res. 2008 Dec;36(6):303-7. doi: 10.1007/s00240-008-0161-5. Epub 2008 Nov 5.

PMID:
18985334
10.

Screening for biochemical abnormalities in urolithiasis patients.

Orakzai N, Hanbury DC, Farrington K.

J Ayub Med Coll Abbottabad. 2004 Apr-Jun;16(2):60-3.

PMID:
15455621
11.

Seasonal variations in urinary risk factors among patients with nephrolithiasis.

Stuart RO 2nd, Hill K, Poindexter J, Pak CY.

J Lithotr Stone Dis. 1991 Jan;3(1):18-27.

PMID:
11536932
12.

Biochemical risk factors for stone formation in a Scottish paediatric hospital population.

MacDougall L, Taheri S, Crofton P.

Ann Clin Biochem. 2010 Mar;47(Pt 2):125-30. doi: 10.1258/acb.2009.009146. Epub 2010 Feb 9.

PMID:
20144971
13.
14.

Should recurrent calcium oxalate stone formers become vegetarians?

Robertson WG, Peacock M, Heyburn PJ, Hanes FA, Rutherford A, Clementson E, Swaminathan R, Clark PB.

Br J Urol. 1979 Dec;51(6):427-31.

PMID:
534817
15.

[Studies of urinary risk factors in urolithiasis].

Ebisuno S, Kitagawa M, Morimoto S, Miyazaki Y, Minakata S, Yasukawa S, Fukatani T, Ohkawa T.

Hinyokika Kiyo. 1985 Jan;31(1):1-15. Japanese.

16.

Role of urinary supersaturation in the evaluation of children with urolithiasis.

Lande MB, Varade W, Erkan E, Niederbracht Y, Schwartz GJ.

Pediatr Nephrol. 2005 Apr;20(4):491-4. Epub 2005 Feb 17.

PMID:
15717161
17.

Urinary risk factors for recurrent calcium stone formation in Thai stone formers.

Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.

J Med Assoc Thai. 2007 Apr;90(4):688-98.

PMID:
17487123
18.

The role of overweight and obesity in calcium oxalate stone formation.

Siener R, Glatz S, Nicolay C, Hesse A.

Obes Res. 2004 Jan;12(1):106-13.

19.

The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.

Wu W, Yang D, Tiselius HG, Ou L, Liang Y, Zhu H, Li S, Zeng G.

Urology. 2014 Apr;83(4):732-7. doi: 10.1016/j.urology.2013.11.012. Epub 2014 Jan 31.

PMID:
24485999
20.

On the relation between citrate and calcium in normal and stone-former subjects.

Conte A, Roca P, Gianotti M, Grases F.

Int Urol Nephrol. 1990;22(1):7-12.

PMID:
2380005

Supplemental Content

Support Center